102 related articles for article (PubMed ID: 8983287)
1. Adaptation of the cellscan technique for the SCM test in breast cancer.
Rahmani H; Deutsch M; Ron I; Gerbat S; Tirosh R; Weinreb A; Chaitchik S; Lalchuk S
Eur J Cancer; 1996 Sep; 32A(10):1758-65. PubMed ID: 8983287
[TBL] [Abstract][Full Text] [Related]
2. Lymphocyte fluorescence polarization measurements with the cellscan system: application to the SCM cancer test.
Deutsch M; Ron I; Weinreb A; Tirosh R; Chaitchik S
Cytometry; 1996 Feb; 23(2):159-65. PubMed ID: 8742175
[TBL] [Abstract][Full Text] [Related]
3. Comments on Adaptation of the Cellscan technique for the SCM test in breast cancer Rahmani et al., Eur. J. Cancer, 32A, no. 10, pp. 1758-1765 1996.
Birindelli S; Colnaghi MI; Pilotti S
Eur J Cancer; 1997 Jul; 33(8):1333-5. PubMed ID: 9301465
[No Abstract] [Full Text] [Related]
4. New SCM (structuredness of the cytoplasmatic matrix)-based approach in breast cancer detection.
Birindelli S; Colnaghi MI; Pilotti S
Tumori; 1996; 82(6):550-3. PubMed ID: 9061062
[TBL] [Abstract][Full Text] [Related]
5. Tumour specificity of the SCM test for cancer diagnosis.
Chaitchik S; Asher O; Deutsch M; Weinreb A
Eur J Cancer Clin Oncol; 1985 Oct; 21(10):1165-70. PubMed ID: 2416568
[TBL] [Abstract][Full Text] [Related]
6. An evaluation of the SCM test for the diagnosis of cancer of the breast.
Chaitchik S; Deutsch M; Asher O; Krauss G; Lebovich P; Michlin H; Weinreb A
Eur J Cancer Clin Oncol; 1988 May; 24(5):861-6. PubMed ID: 3169091
[TBL] [Abstract][Full Text] [Related]
7. A flow system adaptation of the SCM test for detection of lymphocyte response in patients with recurrent breast cancer.
Stewart S; Pritchard KI; Meakin JW; Price GB
Clin Immunol Immunopathol; 1979 Jun; 13(2):171-81. PubMed ID: 156612
[No Abstract] [Full Text] [Related]
8. Application of a static fluorescence-based cytometer (the CellScan) in basic cytometric studies, clinical pharmacology, oncology and clinical immunology.
Harel M; Gilburd B; Schiffenbauer YS; Shoenfeld Y
Clin Dev Immunol; 2005 Sep; 12(3):187-95. PubMed ID: 16295524
[TBL] [Abstract][Full Text] [Related]
9. Application of a static fluorescence-based cytometer: the CellScan in clinical immunology.
Szyper-Kravitz M; Harel M; Gilburd B; Trubniykov E; Schiffenbauer YS; Shoenfeld Y
Lupus; 2006; 15(7):436-41. PubMed ID: 16898179
[TBL] [Abstract][Full Text] [Related]
10. Fluorescence polarisation changes in lymphocyte cytoplasm as a diagnostic test for breast carcinoma.
Ron IG; Deutsch M; Tirosh R; Weinreb A; Eisenthal A; Chaitchik S
Eur J Cancer; 1995 Jun; 31A(6):917-20. PubMed ID: 7646921
[TBL] [Abstract][Full Text] [Related]
11. A clinical assessment of fluorescence polarisation changes in lymphocytes stimulated by phytohaemagglutinin (PHA) in malignant and benign diseases.
Pritchard JA; Sutherland WH; Siddall JE; Bater AJ; Kerby IJ; Deeley TJ; Griffith G; Sinclair R; Davies BH; Rimmer A; Webster DJ
Eur J Cancer Clin Oncol; 1982 Jul; 18(7):651-9. PubMed ID: 6751831
[TBL] [Abstract][Full Text] [Related]
12. The trace and subgrouping of lymphocyte activation by dynamic fluorescence intensity and polarization measurements.
Sunray M; Kaufman M; Zurgil N; Deutsch M
Biochem Biophys Res Commun; 1999 Aug; 261(3):712-9. PubMed ID: 10441491
[TBL] [Abstract][Full Text] [Related]
13. Lymphocyte response to antigen stimulation as measured by fluorescence polarization (SCM test).
Pritchard JA; Sutherland WH
Br J Cancer; 1978 Aug; 38(2):339-43. PubMed ID: 698051
[No Abstract] [Full Text] [Related]
14. Detection of colon cancer by monitoring the intracellular fluorescein fluorescence polarization changes in lymphocytes.
Merimsky O; Duetsch M; Tirosh R; Wohl I; Weinreb A; Chaitchik S
Cancer Detect Prev; 1996; 20(4):300-7. PubMed ID: 8818390
[TBL] [Abstract][Full Text] [Related]
15. Detection of melanoma by monitoring the intracellular fluorescein fluorescence polarization changes in lymphocytes.
Merimsky O; Kaplan B; Deutsch M; Tirosh R; Weinreb A; Chaitchik S
Cancer Detect Prev; 1997; 21(2):167-77. PubMed ID: 9101078
[TBL] [Abstract][Full Text] [Related]
16. Early detection of malignant process in benign lesions of breast tumor by measurements of changes in structuredness of cytoplasmic matrix in circulating lymphocytes (SCM test) reinduced in vitro by specific tumor antigen.
Klein O; Linn S; Davidson C; Hadary A; Shukha A; Zidan J; Eitan A; Kook AI
Breast; 2002 Dec; 11(6):478-83. PubMed ID: 14965713
[TBL] [Abstract][Full Text] [Related]
17. An approach for high sensitivity detection of prostate cancer by analysis of changes in structuredness of the cytoplasmic matrix of lymphocytes specifically induced by PSA-ACT.
Klein O; Lin S; Embon O; Sazbon A; Zidan J; Kook AI
J Urol; 1999 Jun; 161(6):1994-6. PubMed ID: 10332488
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of fluorescence polarization of human blood lymphocytes (SCM test) in the diagnosis of cancer.
Schnuda ND
Cancer; 1980 Sep; 46(5):1164-73. PubMed ID: 7214300
[TBL] [Abstract][Full Text] [Related]
19. Response of T lymphocytes to phytohaemagglutinin (PHA) and to cancer-tissue-associated antigens, measured by the intracellular fluorescence polarization technique (SCM test).
Orjasaeter H; Jordfald G; Svendsen I
Br J Cancer; 1979 Oct; 40(4):628-33. PubMed ID: 387060
[TBL] [Abstract][Full Text] [Related]
20. Clinical application of static fluorescence-based cytometry, Cellscan, in cutaneous adverse drug reaction.
Salameh F; Kravitz MS; Barzilai A; Baum S; Shoenfeld Y; Schiffenbauer Y; Trubniykov E; Trau H
J Dermatol; 2011 May; 38(5):447-55. PubMed ID: 21352273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
